Vulvar Diseases clinical trials
The registry lists 21 studies for Vulvar Diseases across more than 10 countries. 6 are recruiting or about to start. 7 of them are mainly about Vulvar Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-08-11. Counting its 6 narrower conditions too, such as Vulvar Neoplasms: 512 studies, 117 open.
Get an email when these change. Save the Vulvar Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Children's Mercy Hospital Kansas City (1) · University of Rochester (1) · Clinica Dermatologica Arbache ltda (1) · University of Virginia (1) · Incyte Corporation (1) · University of Aarhus (1) · Vaginal Biome Science (1) · Marengo Therapeutics, Inc. (1)
What is being tested here
Drugs under test in Vulvar Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 3
- Dec 2026Large Algorithm Setting and Validation Study · Nanopath, Inc
- Dec 2026Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) · Frantz Viral Therapeutics, LLC
- Sep 2027A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors · Marengo Therapeutics, Inc.
Who these studies take
Of the 6 Vulvar Diseases studies recruiting now, 5 (83%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (17%) take children under 18. 5 (83%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (17%) | 0 (0%) |
| 18 | 6 (100%) | 1 (17%) |
| 30 | 6 (100%) | 1 (17%) |
| 40 | 6 (100%) | 1 (17%) |
| 50 | 6 (100%) | 1 (17%) |
| 65 | 6 (100%) | 1 (17%) |
| 75 | 6 (100%) | 1 (17%) |
| 85 | 6 (100%) | 1 (17%) |
Across all 21 studies, recruiting or not: 19% stop at 75 or younger and 19% at 65; 24% take children; 90% are for women only and 0% for men only; 29% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 21 of 21. search them.
- A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsRecruitingNCT05592626Phase 1/24 countries
- Large Algorithm Setting and Validation StudyRecruitingNCT076074701 country
- Danish Vulva Cancer Recurrence StudyRecruitingNCT06495554Not applicable1 country
- Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant LesionsRecruitingNCT06070454Not applicable1 country
- Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)RecruitingNCT06075264Phase 21 country
- Vulvar Disease in Nigeria Observational StudyRecruitingNCT058900921 country
- Different Education Methods and Self Vulvar Examination (SVE)Active, not recruitingNCT07479459Not applicable1 country
- E7 TCR T Cells for Human Papillomavirus-Associated CancersCompletedNCT02858310Phase 1/21 country
- Lichen Sclerosus - Treatment With Triamcinolone Acetonide: Injections (Syringe and Needle) x Micro Injections (MMP Technique)CompletedNCT06079645Not applicable1 country
- Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar VestibulitisCompletedNCT00004316Phase 1/21 country
- Treatment of Prepubertal Labial AdhesionsCompletedNCT02218463Not applicable1 country
- Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)CompletedNCT03792516Phase 11 country
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Lichen SclerosusCompletedNCT05593445Phase 22 countries
- Effects of Flourish HEC on Localized Provoked VulvodyniaCompletedNCT05478746Not applicable1 country
- Treatment Prior to Injection and Biopsy of the VulvaTerminatedNCT03444727Not applicable1 country
- Vulvar Mucosal Specialty Clinic Chart ReviewTerminatedNCT028812291 country
- Diagnostic Accuracy of "Three Rings Vulvoscopy" for Detection of Vulvar DermatosisCompletedNCT02732145Not applicable1 country
- Evaluation of the Role of Vibrational Spectroscopy in the Assessment of Vulval DiseaseSuspendedNCT022239751 country
- Efficacy Study of Topical Application of Nifedipine Cream to Treat Vulvar VestibulitisCompletedNCT00496184Phase 31 country
- Vulvar Vestibulitis Clinical Trial: Desipramine-LidocaineCompletedNCT00276068Not applicable1 country
- Botox on Vulvar VestibulitisStatus unknownNCT00119886Phase 41 country